The Role of Yamanaka Factors in the Induction of Pluripotent Stem Cells In the fall of 2006, Shinya Yamanaka reported a method that turned ordinary body cells into cells more like those of mouse embryonic stem cells (Baker 962). In introducing his method, he wrote that pluripotent stem cells multiply rapidly while maintaining their pluripotency , or ability to differentiate. Therefore, human embryonic stem cells would be excellent donor sources for cell transplantation therapies, were there not extensive ethical issues as well as the high risk of rejection reactions. “It may be possible to overcome these issues by generating pluripotent stem cells directly from a patient’s somatic cells. That somatic cell nuclei acquire an embryonic...The end:
.....st and Furious.” Nature 458.23 (2009): 962-965. Kim, Peter Geon and George Q. Daley. “Application of Induced Pluripotent Stem Cells to Hematologic Disease.” Cytotherapy 11.8 (2009): 980-989. Miura, Kyoko, et al. “Variation in the Safety of Induced Pluripotent Stem Cell Lines.” Nature Biotechnology 27.8 (2009): 743-745. Nagata, Shogo, et al. “Efficient Reprogramming of Human and Mouse Primary Extra-Embryonic Cells to Pluripotent Stem Cells.” Genes to Cells 14 (2009): 1395-1404. Pera , Martin F. and Kouichi Hasegawa. “Simpler and Safer Cell Reprogramming.” Nature Biotechnology 26.1 (2008): 59-60. Yamanaka, Shinya. “Induction of Pluripotent Stem Cells from Mouse Fibroblasts by Four Transcription Factors.” Cell Proliferation 41.1 (2008): 51-56.